# Comparison of Escalating Doses of IncobotulinumtoxinA (Xeomin®) in the Treatment of Glabellar Rhytids

> **NCT01583478** · PHASE4 · UNKNOWN · sponsor: **The Maas Clinic** · enrollment: 15 (estimated)

## Conditions studied

- Skin Aging
- Elastosis Senilis

## Interventions

- **BIOLOGICAL:** incobotulinumtoxinA

## Key facts

- **NCT ID:** NCT01583478
- **Lead sponsor:** The Maas Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-09
- **Primary completion:** 2015-10
- **Final completion:** 2015-12
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2014-09-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01583478

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01583478, "Comparison of Escalating Doses of IncobotulinumtoxinA (Xeomin®) in the Treatment of Glabellar Rhytids". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT01583478. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*